openPR Logo
Press release

Drug Discovery Market Size, Share, Growth Forecast 2023-2032

06-20-2024 04:23 PM CET | Health & Medicine

Press release from: Acumen Research and Consulting

Drug Discovery Market Size, Share, Growth Forecast 2023-2032

In recent years, the global drug discovery market has witnessed remarkable growth, driven by technological advancements, increasing prevalence of chronic diseases, and rising investments in research and development. As of 2022, the market was valued at USD 81.5 billion and is projected to reach USD 181.4 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.5% from 2023 to 2032. This surge underscores a dynamic landscape characterized by evolving trends, robust drivers, and significant opportunities across regions and sectors.

Download Free Drug Discovery Market Sample Report Here: (Including Full TOC, List of Tables & Figures, Chart) https://www.acumenresearchandconsulting.com/request-sample/3332

Current Market Trends

The drug discovery market is experiencing a paradigm shift due to several key trends. Firstly, there's a notable rise in personalized medicine, driven by advancements in genomics and biotechnology. This shift allows for the development of therapies tailored to individual genetic profiles, enhancing treatment efficacy and patient outcomes. Additionally, there is an increasing emphasis on biologics and targeted therapies, which offer precise mechanisms of action and reduced side effects compared to traditional treatments.

Moreover, artificial intelligence (AI) and machine learning are revolutionizing drug discovery processes. These technologies streamline data analysis, predict compound properties, and optimize clinical trial designs, thereby accelerating the drug development timeline. Furthermore, the adoption of high-throughput screening techniques and automation in laboratories enhances efficiency and scalability in drug discovery workflows.

REQUEST A $1000 DISCOUNT ON CREDIT CARD PURCHASE: https://www.acumenresearchandconsulting.com/inquiry-before-buying/3332

Drivers and Restraints

The growth of the drug discovery market is propelled by several drivers. The expanding global geriatric population, susceptible to chronic diseases like cancer, cardiovascular disorders, and neurodegenerative conditions, is increasing the demand for novel therapeutics. Additionally, government initiatives and funding support for research in life sciences stimulate innovation and drive market expansion.

Conversely, the high costs associated with drug discovery and development pose significant challenges. The complexity of biological systems and stringent regulatory requirements further intensify these hurdles. However, advancements in technologies such as CRISPR gene editing and organ-on-chip models hold promise in overcoming these challenges by offering more accurate disease models and enhancing preclinical testing efficiency.

Competitive Landscape and Future Growth Prospects

The drug discovery market is highly competitive, characterized by numerous players ranging from pharmaceutical giants to biotechnology startups. Key players are investing in strategic collaborations, mergers, and acquisitions to strengthen their research capabilities and expand market share. Additionally, partnerships with AI and biotechnology firms are enhancing innovation in drug discovery processes.

Looking ahead, the future growth prospects of the market remain robust, driven by advancements in omics technologies, increasing adoption of digital health solutions, and growing focus on rare diseases and orphan drugs. Furthermore, the COVID-19 pandemic has underscored the importance of agile drug discovery platforms and accelerated the development of antiviral therapies and vaccines, paving the way for future innovations in infectious disease management.

Table Of Content

CHAPTER 1. Industry Overview of Drug Discovery Market
CHAPTER 2. Research Approach
CHAPTER 3. Market Dynamics And Competition Analysis
CHAPTER 4. Drug Discovery Market By Drug Type
CHAPTER 5. Drug Discovery Market By Technology
CHAPTER 6. Drug Discovery Market By End-User
CHAPTER 7. North America Drug Discovery Market By Country
CHAPTER 8. Europe Drug Discovery Market By Country
CHAPTER 9. Asia Pacific Drug Discovery Market By Country
CHAPTER 10. Latin America Drug Discovery Market By Country
CHAPTER 11. Middle East & Africa Drug Discovery Market By Country
CHAPTER 12. Player Analysis Of Drug Discovery Market
CHAPTER 13. Company Profile

Drug Discovery Market Segmentation:

The worldwide market for drug discovery is split based on drug type, technology, end-user, and geography.

Drug Discovery Drug Types

Small Molecule Drugs
Biologic Drugs

Drug Discovery Technologies

High Throughput Screening
Spectroscopy
Combinatorial Chemistry
Biochips
Pharmacogenomics and Pharmacogenetics
Bioinformatics
Metabolomics
Nanotechnology
Other Technologies

Drug Discovery End-Users

Pharmaceutical Companies
Contract Research Organizations (CROs)
Other End-Users

Opportunities and Regional Insights

Geographically, North America dominates the drug discovery market, attributed to a strong presence of pharmaceutical companies, robust research infrastructure, and favorable government policies supporting innovation. However, Asia-Pacific is witnessing rapid growth, driven by increasing healthcare expenditure, expanding biotechnology sector, and rising R&D investments in countries like China and India.

Opportunities abound in emerging markets as pharmaceutical companies increasingly focus on expanding their footprint in these regions. Moreover, collaborations between academia, industry, and research institutions foster innovation and accelerate drug discovery efforts globally.

Market Players:

Some of the top drug discovery companies offered in our report includes Abbott Laboratories Inc., Agilent Technologies Inc., AstraZeneca PLC, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Merck & Co. Inc., Pfizer Inc., and Shimadzu Corp.

Buy the premium market research report here: https://www.acumenresearchandconsulting.com/buy-now/0/3332

Find more such market research reports on our website or contact us directly

Write to us at sales@acumenresearchandconsulting.com

Call us on +918983225533

or +13474743864

Browse for more Related Reports: https://www.globenewswire.com/en/news-release/2023/09/04/2736814/0/en/Drug-Discovery-Market-Size-to-Reach-USD-181-4-Billion-by-2032-with-a-CAGR-of-8-5-According-to-Acumen-Research-and-Consulting.html

201, Vaidehi-Saaket, Baner - Pashan Link Rd, Pashan, Pune, Maharashtra 411021

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Discovery Market Size, Share, Growth Forecast 2023-2032 here

News-ID: 3547094 • Views:

More Releases from Acumen Research and Consulting

Industrial Filters Market Size, Share, Growth Trends and Forecast 2023 - 2032
Industrial Filters Market Size, Share, Growth Trends and Forecast 2023 - 2032
The global industrial filters market is poised for significant growth, driven by increasing demand across various industries such as manufacturing, automotive, and chemicals. According to recent research conducted by Acumen Research and Consulting, the industrial filters market is projected to achieve a substantial market size by 2032. This press release provides a comprehensive analysis of the industrial filters market, highlighting key trends, growth drivers, and future prospects. ------------------------------------------------------------------------------------------------------------------- REQUEST A $1000 DISCOUNT
Antimicrobial Coatings Market Size, Share, Growth, and Forecast 2023-2032
Antimicrobial Coatings Market Size, Share, Growth, and Forecast 2023-2032
The global Antimicrobial Coatings Market is experiencing a period of unprecedented growth, driven by increasing demand across various industries such as healthcare, construction, and food & beverage. According to a recent report by Acumen Research And Consulting, the market is projected to achieve significant milestones by 2032, with notable advancements in technology and widespread adoption across numerous applications. ------------------------------------------------------------------------------------------------------------------- REQUEST A $1000 DISCOUNT ON CREDIT CARD PURCHASE: https://www.acumenresearchandconsulting.com/inquiry-before-buying/2652 ------------------------------------------------------------------------------------------------------------------- Market Overview: The Antimicrobial Coatings Market,
Iron Oxide Pigment Market Size, Share, Growth Forecast 2023-2032
Iron Oxide Pigment Market Size, Share, Growth Forecast 2023-2032
The Iron Oxide Pigment Market has demonstrated consistent growth due to increasing demand across various industries, including construction, paints and coatings, plastics, and cosmetics. The market was valued at USD 2,024 in 2023 and is expected to reach USD 2,978 by 2032, growing at a CAGR of 4.5 from 2024 to 2032. ------------------------------------------------------------------------------------------------------------------- REQUEST A $1000 DISCOUNT ON CREDIT CARD PURCHASE: https://www.acumenresearchandconsulting.com/inquiry-before-buying/2656 ------------------------------------------------------------------------------------------------------------------- Key Market Drivers: Several factors are driving the growth of the Iron
Expanded Polystyrene Market Growth Analysis and Forecasts 2023-2032
Expanded Polystyrene Market Growth Analysis and Forecasts 2023-2032
The Expanded Polystyrene (EPS) market is set to witness remarkable growth in the coming years, driven by increasing demand from the packaging, construction, and automotive industries. According to the latest report by Acumen Research And Consulting, the global EPS market is projected to achieve a market size of USD 27,592 Million by 2032, growing at a CAGR of 4.9% from 2023 to 2032. This press release delves into the key

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug